Clinical Trials Browser

Phase 3 × INDUSTRY × exemestane × Clear all

NCT06016738 2026-03-13

OPERA-01

Phase 3 Recruiting

Breast Neoplasms

NCT07174336 2026-03-06

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Phase 3 Recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT05827081 2026-03-02

Adjuvant WIDER

Phase 3 Recruiting

Breast Neoplasms, Breast Neoplasms, Male

NCT05306340 2026-01-30

A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

Phase 3 Active not recruiting

Breast Neoplasms

NCT05514054 2026-01-29

EMBER-4

Phase 3 Active not recruiting

Breast Neoplasms

NCT05645536 2026-01-12

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

Phase 3 Enrolling by invitation

Breast Neoplasms, Neoplasms

NCT06680921 2025-09-22

A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

Phase 3 Recruiting

Breast Neoplasms

NCT03778931 2025-09-15

EMERALD

Phase 3 Completed

478 enrolled 16 charts 1 FDA

Breast Neoplasms

NCT04975308 2025-07-11

EMBER-3

Phase 3 Active not recruiting

874 enrolled 29 charts 1 FDA

Breast Neoplasms, Neoplasm Metastasis

NCT05952557 2025-06-19

CAMBRIA-2

Phase 3 Recruiting

Breast Neoplasms

NCT05065411 2024-02-26

VERU-024

Phase 3 Terminated

Breast Neoplasms

NCT04869943 2024-01-26

ARTEST

Phase 3 Terminated

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT02482753 2022-01-12

Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT03538171 2021-07-09

Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer

Phase 3 Unknown

Advanced Breast Cancer

NCT03176238 2020-04-07

EVEREXES

Phase 3 Completed

235 enrolled 11 charts

Breast Neoplasms

NCT00863655 2017-05-02

BOLERO-2

Phase 3 Completed

724 enrolled 20 charts

Breast Neoplasms

NCT01626222 2017-02-23

MACS2096

Phase 3 Completed

Breast Neoplasms

NCT00036270 2015-10-28

TEAM

Phase 3 Completed

9,779 enrolled 13 charts

Breast Neoplasms

NCT00065325 2015-02-24

EFECT

Phase 3 Completed

Breast Neoplasms

NCT00038467 2014-05-07

IES

Phase 3 Completed

4,740 enrolled 31 charts

Breast Neoplasms

NCT00143390 2012-01-25

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

Phase 3 Completed

298 enrolled 13 charts

Breast Neoplasms

NCT00279448 2011-12-23

TEAM

Phase 3 Completed

Breast Neoplasms

NCT01237327 2011-05-06

Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer

Phase 3 Completed

84 enrolled 12 charts

Breast Neoplasms